Trace Minerals in Patients with End-Stage Renal Disease

Seminars in Dialysis

Volumn 23, Issue 6, 2010, Pages 561-570

  Kasama, Richard K ^a  

^a Department of Anesthesiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID; TRACE ELEMENT;

ARTICLE; CHRONIC KIDNEY FAILURE; HUMAN; KIDNEY; METABOLISM; RENAL REPLACEMENT THERAPY;

DIALYSIS SOLUTIONS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; TRACE ELEMENTS;

EID: 78650372525     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2010.00793.x     Document Type: Article

References (158)

1. Dietary Reference Intakes. Food and Nutrition Information Center, National Agricultural Library, United States Department of Agriculture., accessed August 30, 2010
2. Anonymous: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: Institute of Medicine Food and Nutrition Board, National Academy Press, 2001
3. Trumbo P, Yates AA, Schlicker S, Poos M: Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 101(3):294-301, 2001
4. Hosokawa S, Oyamaguchi A, Yoshida O: Trace elements and complications in patients undergoing chronic hemodialysis. Nephron 55(4):375-379, 1990
5. Sandstead HH: Trace elements in uremia and hemodialysis. Am J Clin Nutr 33(7):1501-1508, 1980
6. Vanholder R, Cornelis R, Dhondt A, Lameire N: The role of trace elements in uraemic toxicity. Nephrol Dial Transplant 17(Suppl. 2):2-8, 2002
7. Vanholder R, Cornelis R, Dhondt A, Lameire N: Trace element metabolism in renal disease. In: Kopple JD, Massry SG (eds). Nutritional Management of Renal Disease, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 2004:299-313
8. Fassett RG, Robertson IK, Geraghty DP, Ball MJ, Coombes JS: Dietary intake of patients with chronic kidney disease entering the LORD trial: adjusting for underreporting. J Ren Nutr 17(4):235-242, 2007
9. Hambidge M: Biomarkers of trace mineral intake and status. J Nutr 133(Suppl. 3):948S-955S, 2003
10. ., accessed August 29, 2010
11. Dobson DA: What is the current economic contribution of the dietary supplement industry to the U.S. economy?, accessed November 11, 2010
12. Heaney RP: Lead in calcium supplements: cause for alarm or celebration? JAMA 284(11):1432-1433, 2000
13. Bent S: Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med 23(6):854-859, 2008
14. Patel TV, Singh AK: Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions. Semin Nephrol 29(2):105-112, 2009
15. Kovesdy CP: Iron and clinical outcomes in dialysis and non-dialysis-dependent chronic kidney disease patients. Adv Chronic Kidney Dis 16(2):109-116, 2009
16. Kovesdy CP, Kalantar-Zadeh K: Iron therapy in chronic kidney disease: current controversies. J Ren Care 35(Suppl. 2):14-24, 2009
17. Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C, Manns B, Thadhani R, Gill J: Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med 7:25, 2009
18. Hirano S, Suzuki KT: Exposure, metabolism, and toxicity of rare earths and related compounds. Environ Health Perspect 104(Suppl. 1):85-95, 1996
19. Barceloux DG: Vanadium. J Toxicol Clin Toxicol 37(2):265-278, 1999
20. Agarwal R, Brunelli SM, Williams K, Mitchell MD, Feldman HI, Umscheid CA: Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis. Nephrol Dial Transplant 24(3):856-863, 2009
21. Smythe WR, Alfrey AC, Craswell PW, Crouch CA, Ibels LS, Kubo H, Nunnelley LL, Rudolph H: Trace element abnormalities in chronic uremia. Ann Intern Med 96(3):302-310, 1982
22. D'Haese PC, Couttenye MM, Lamberts LV, Elseviers MM, Goodman WG, Schrooten I, Cabrera WE, De Broe ME: Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 45(9):1548-1556, 1999
23. Hung KY, Ho CY, Kuo YM, Lee SH, Hseih SJ, Yang CS, Peng CJ, Wu DJ, Hung JT, Chen PY, Chen JS, Chen WY: Trace elements burden in geriatric hemodialysis patients: a prospective multicenter collaborative study. Int J Artif Organs 20(10):553-556, 1997
24. Krachler M, Wirnsberger GH: Long-term changes of plasma trace element concentrations in chronic hemodialysis patients. Blood Purif 18(2):138-143, 2000
25. Hunt CD, Stoecker BJ: Deliberations and evaluations of the approaches, endpoints and paradigms for boron, chromium and fluoride dietary recommendations. J Nutr 126(Suppl. 9):2441S-2451S, 1996
26. Nielsen FH: Is boron nutritionally relevant? Nutr Rev 66(4):183-191, 2008
27. Pahl MV, Culver BD, Vaziri ND: Boron and the kidney. J Ren Nutr 15(4):362-370, 2005
28. Usuda K, Kono K, Iguchi K, Nishiura K, Miyata K, Shimahara M, Konda T, Hashiguchi N, Senda J: Hemodialysis effect on serum boron level in the patients with long term hemodialysis. Sci Total Environ 191(3):283-290, 1996
29. Goldhaber SB: Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol 38(2):232-242, 2003
30. D'Haese PC, De Broe ME: Adequacy of dialysis: trace elements in dialysis fluids. Nephrol Dial Transplant 11(Suppl. 2):92-97, 1996
31. Zima T, Mestek O, Tesar V, Tesarova P, Nemecek K, Zak A, Zeman M: Chromium levels in patients with internal diseases. Biochem Mol Biol Int 46(2):365-374, 1998
32. Cerulli J, Grabe DW, Gauthier I, Malone M, McGoldrick MD: Chromium picolinate toxicity. Ann Pharmacother 32(4):428-431, 1998
33. Martin WR, Fuller RE: Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 18(4):860-862, 1998
34. Jeejeebhoy KN: The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev 57(11):329-335, 1999
35. Reinhardt C, Vaccaro DE, Groman EV: Adverse effects of gadolinium administration in hemodialysis patients: a role for chromium supplementation? Am J Kidney Dis 52(5):1021; author reply 21-2, 2008
36. Griffith DP, Liff DA, Ziegler TR, Esper GJ, Winton EF: Acquired copper deficiency: a potentially serious and preventable complication following gastric bypass surgery. Obesity (Silver Spring) 17(4):827-831, 2009
37. Kumar N: Copper deficiency myelopathy (human swayback). Mayo Clin Proc 81(10):1371-1384, 2006
38. Higuchi T, Matsukawa Y, Okada K, Oikawa O, Yamazaki T, Ohnishi Y, Fujita T, Fukuda N, Soma M, Matsumoto K: Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemia. Intern Med 45(5):271-273, 2006
39. Yaldizli O, Johansson U, Gizewski ER, Maschke M: Copper deficiency myelopathy induced by repetitive parenteral zinc supplementation during chronic hemodialysis. J Neurol 253(11):1507-1509, 2006
40. Sinkovic A, Strdin A, Svensek F: Severe acute copper sulphate poisoning: a case report. Arh Hig Rada Toksikol 59(1):31-35, 2008
41. Bhowmik D, Mathur R, Bhargava Y, Dinda AK, Agarwal SK, Tiwari SC, Dash SC: Chronic interstitial nephritis following parenteral copper sulfate poisoning. Ren Fail 23(5):731-735, 2001
42. Oldenquist G, Salem M: Parenteral copper sulfate poisoning causing acute renal failure. Nephrol Dial Transplant 14(2):441-443, 1999
43. Franchitto N, Gandia-Mailly P, Georges B, Galinier A, Telmon N, Ducasse JL, Rouge D: Acute copper sulphate poisoning: a case report and literature review. Resuscitation 78(1):92-96, 2008
44. Hosokawa S, Nishitani H, Tomita K, Tomoyoshi T, Nishio T, Sawanishi K, Yoshida O: Serum copper concentration changes in chronic hemodialyzed patients. Uremia Invest 9(1):63-67, 1985
45. Emenaker NJ, DiSilvestro RA, Nahman Jr NS, Percival S: Copper-related blood indexes in kidney dialysis patients. Am J Clin Nutr 64(5):757-760, 1996
46. Navarro-Alarcon M, Reyes-Perez A, Lopez-Garcia H, Palomares-Bayo M, Olalla-Herrera M, Lopez-Martinez MC: Longitudinal study of serum zinc and copper levels in hemodialysis patients and their relation to biochemical markers. Biol Trace Elem Res 113(3):209-222, 2006
47. Hsieh YY, Shen WS, Lee LY, Wu TL, Ning HC, Sun CF: Long-term changes in trace elements in patients undergoing chronic hemodialysis. Biol Trace Elem Res 109(2):115-121, 2006
48. Villanueva J, Hoshino M, Katou H, Kardos J, Hasegawa K, Naiki H, Goto Y: Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis. Protein Sci 13(3):797-809, 2004
49. Morgan CJ, Gelfand M, Atreya C, Miranker AD: Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation. J Mol Biol 309(2):339-345, 2001
50. Healy H, Reith D, Morgan C, Clague A, Westhuyzen J: Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure? Ann Clin Lab Sci 30(3):295-304, 2000
51. Gessner BD, Beller M, Middaugh JP, Whitford GM: Acute fluoride poisoning from a public water system. N Engl J Med 330(2):95-99, 1994
52. Bradberry SM, Vale JA: Disturbances of potassium homeostasis in poisoning. J Toxicol Clin Toxicol 33(4):295-310, 1995
53. Nicolay A, Bertocchio P, Bargas E, Coudore F, Al Chahin G, Reynier JP: Hyperkalemia risks in hemodialysed patients consuming fluoride-rich water. Clin Chim Acta 281(1-2):29-36, 1999
54. Arduino MJ: CDC investigations of noninfectious outbreaks of adverse events in hemodialysis facilities, 1979-1999. Semin Dial 13(2):86-91, 2000
55. Bland LA, Arnow PM, Arduino MJ, Bova J, McAllister SK: Potential hazards of deionization systems used for water purification in hemodialysis. Artif Organs 20(1):2-7, 1996
56. al-Wakeel JS, Mitwalli AH, Huraib S, al-Mohaya S, Abu-Aisha H, Chaudhary AR, al-Majed SA, Memon N: Serum ionic fluoride levels in haemodialysis and continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant 12(7):1420-1424, 1997
57. Usuda K, Kono K, Watanabe T, Dote T, Shimizu H, Tominaga M, Koizumi C, Nishiura H, Goto E, Nakaya H, Arisue M, Fukutomi A: Hemodialyzability of ionizable fluoride in hemodialysis session. Sci Total Environ 297(1-3):183-191, 2002
58. Ng A, Hercz G, Kandel R, Grynpas MD: Association between fluoride, magnesium, aluminum, and bone quality in renal osteodystrophy. Bone 34(1):216-224, 2004
59. Cohen-Solal ME, Augry F, Mauras Y, Morieux C, Allain P, de Vernejoul MC: Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients. Nephrol Dial Transplant 17(3):449-454, 2002
60. Caldwell KL, Miller GA, Wang RY, Jain RB, Jones RL: Iodine status of the U.S. population, National Health and Nutrition Examination Survey 2003-2004. Thyroid 18(11):1207-1214, 2008
61. Murcutt G, Edwards J, Boakye J, Davenport A: Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy. Kidney Int 73(11):1316-1319, 2008
62. Kaptein EM: Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 17(1):45-63, 1996
63. Napolitano G, Bonomini M, Bomba G, Bucci I, Todisco V, Albertazzi A, Monaco F: Thyroid function and plasma selenium in chronic uremic patients on hemodialysis treatment. Biol Trace Elem Res 55(3):221-230, 1996
64. Ramirez G, Jubiz W, Gutch CF, Bloomer HA, Siegler R, Kolff WJ: Thyroid abnormalities in renal failure. A study of 53 patients on chronic hemodialysis. Ann Intern Med 79(4):500-504, 1973
65. Kutlay S, Atli T, Koseogullari O, Nergizoglu G, Duman N, Gullu S: Thyroid disorders in hemodialysis patients in an iodine-deficient community. Artif Organs 29(4):329-332, 2005
66. Kanakiriya S, De Chazal I, Nath KA, Haugen EN, Albright RC, Juncos LA: Iodine toxicity treated with hemodialysis and continuous venovenous hemodiafiltration. Am J Kidney Dis 41(3):702-708, 2003
67. Dobson AW, Erikson KM, Aschner M: Manganese neurotoxicity. Ann N Y Acad Sci 1012:115-128, 2004
68. Ohtake T, Negishi K, Okamoto K, Oka M, Maesato K, Moriya H, Kobayashi S: Manganese-induced Parkinsonism in a patient undergoing maintenance hemodialysis. Am J Kidney Dis 46(4):749-753, 2005
69. Taylor PA, Price JD: Acute manganese intoxication and pancreatitis in a patient treated with a contaminated dialysate. Can Med Assoc J 126(5):503-505, 1982
70. da Silva CJ, da Rocha AJ, Jeronymo S, Mendes MF, Milani FT, Maia Jr AC, Braga FT, Sens YA, Miorin LA: A preliminary study revealing a new association in patients undergoing maintenance hemodialysis: manganism symptoms and T1 hyperintense changes in the basal ganglia. AJNR Am J Neuroradiol 28(8):1474-1479, 2007
71. Vyskocil A, Viau C: Assessment of molybdenum toxicity in humans. J Appl Toxicol 19(3):185-192, 1999
72. Meeker JD, Rossano MG, Protas B, Diamond MP, Puscheck E, Daly D, Paneth N, Wirth JJ: Cadmium, lead, and other metals in relation to semen quality: human evidence for molybdenum as a male reproductive toxicant. Environ Health Perspect 116(11):1473-1479, 2008
73. Hosokawa S, Yoshida O: Clinical studies on molybdenum in patients requiring long-term hemodialysis. ASAIO J 40(3):M445-M449, 1994
74. Barceloux DG: Nickel. J Toxicol Clin Toxicol 37(2):239-258, 1999
75. Nielsen FH: Fluoride, vanadium, nickel, arsenic, and silicon in total parenteral nutrition. Bull N Y Acad Med 60(2):177-195, 1984
76. Kazi TG, Jalbani N, Kazi N, Arain MB, Jamali MK, Afridi HI, Kandhro GA, Sarfraz RA, Shah AQ, Ansari R: Estimation of toxic metals in scalp hair samples of chronic kidney patients. Biol Trace Elem Res 127(1):16-27, 2009
77. Hopfer SM, Fay WP, Sunderman Jr FW: Serum nickel concentrations in hemodialysis patients with environmental exposure. Ann Clin Lab Sci 19(3):161-167, 1989
78. Hosokawa S, Yoshida O: Effect of recombinant human erythropoietin (rHuEPO) on protein, zinc (Zn), nickel (Ni) and manganese (Mn) in patients undergoing chronic haemodialysis. Int Urol Nephrol 27(2):207-214, 1995
79. Webster JD, Parker TF, Alfrey AC, Smythe WR, Kubo H, Neal G, Hull AR: Acute nickel intoxication by dialysis. Ann Intern Med 92(5):631-633, 1980
80. Olerud JE, Lee MY, Uvelli DA, Goble GJ, Babb AL: Presumptive nickel dermatitis from hemodialysis. Arch Dermatol 120(8):1066-1068, 1984
81. Katko M, Kiss I, Karpati I, Kadar A, Matyus J, Csongradi E, Posta J, Paragh G, Balla J, Kovacs B, Varga Z: Relationship between serum nickel and homocysteine concentration in hemodialysis patients. Biol Trace Elem Res 124(3):195-205, 2008
82. Patrick L: Selenium biochemistry and cancer: a review of the literature. Altern Med Rev 9(3):239-258, 2004
83. Rederstorff M, Krol A, Lescure A: Understanding the importance of selenium and selenoproteins in muscle function. Cell Mol Life Sci 63(1):52-59, 2006
84. Chen J, Berry MJ: Selenium and selenoproteins in the brain and brain diseases. J Neurochem 86(1):1-12, 2003
85. Beckett GJ, Arthur JR: Selenium and endocrine systems. J Endocrinol 184(3):455-465, 2005
86. Stapleton SR: Introduction: the selenium conundrum. Cell Mol Life Sci 57(13-14):1823-1824, 2000
87. Sutter ME, Thomas JD, Brown J, Morgan B: Selenium toxicity: a case of selenosis caused by a nutritional supplement. Ann Intern Med 148(12):970-971, 2008
88. MacFarquhar JK, Broussard DL, Melstrom P, Hutchinson R, Wolkin A, Martin C, Burk RF, Dunn JR, Green AL, Hammond R, Schaffner W, Jones TF: Acute selenium toxicity associated with a dietary supplement. Arch Intern Med 170(3):256-261, 2010
89. Fan AM, Kizer KW: Selenium. Nutritional, toxicologic, and clinical aspects. West J Med 153(2):160-167, 1990
90. Yang GQ, Wang SZ, Zhou RH, Sun SZ: Endemic selenium intoxication of humans in China. Am J Clin Nutr 37(5):872-881, 1983
91. Kamble P, Mohsin N, Jha A, Date A, Upadhaya A, Mohammad E, Khalil M, Pakkyara A, Budruddin M: Selenium intoxication with selenite broth resulting in acute renal failure and severe gastritis. Saudi J Kidney Dis Transpl 20(1):106-111, 2009
92. Chen B, Lamberts LV, Behets GJ, Zhao T, Zhou M, Liu G, Hou X, Guan G, D'Haese PC: Selenium, lead, and cadmium levels in renal failure patients in China. Biol Trace Elem Res 131(1):1-12, 2009
93. Yavuz O, Bicik Z, Cinar Y, Guney Y, Guler S: The effect of different dialysis membranes on oxidative stress and selenium status. Clin Chim Acta 346(2):153-160, 2004
94. Kalantar-Zadeh K, Kopple JD: Trace elements and vitamins in maintenance dialysis patients. Adv Ren Replace Ther 10(3):170-182, 2003
95. Zagrodzki P, Barton H, Walas S, Folta M, Stompor T, Janusz-Grzybowska E, Drozdz M, Sulowicz W: Selenium status indices, laboratory data, and selected biochemical parameters in end-stage renal disease patients. Biol Trace Elem Res 116(1):29-41, 2007
96. Milly K, Wit L, Diskin C, Tulley R: Selenium in renal failure patients. Nephron 61(2):139-144, 1992
97. Zima T, Mestek O, Nemecek K, Bartova V, Fialova J, Tesar V, Suchanek M: Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif 16(5):253-260, 1998
98. Zachara BA, Wlodarczyk Z, Masztalerz M, Adamowicz A, Gromadzinska J, Wasowicz W: Selenium concentrations and glutathione peroxidase activities in blood of patients before and after allogenic kidney transplantation. Biol Trace Elem Res 97(1):1-13, 2004
99. Bober J, Kwiatkowska E, Kedzierska K, Olszewska M, Golebiewska E, Stachowska E, Kucharska E, Ciechanowski K, Chlubek D: Influence of glucose in the dialysate on the activity of erythrocyte-glutathione-peroxidase and blood selenium concentration in hemodialyzed patients. Arch Med Res 38(3):330-336, 2007
100. Sriram K, Abraham G: Loss of zinc and selenium does not occur through peritoneal dialysis. Nutrition 16(11-12):1047-1051, 2000
101. Apostolidis NS, Panoussopoulos DG, Stamou KM, Kekis PB, Paradellis TP, Karydas AG, Zarkadas C, Zirogiannis PN, Manouras AJ: Selenium metabolism in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 22(3):400-404, 2002
102. Mishra V, Baines M, Perry SE, McLaughlin PJ, Carson J, Wenstone R, Shenkin A: Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr 26(1):41-50, 2007
103. Temple KA, Smith AM, Cockram DB: Selenate-supplemented nutritional formula increases plasma selenium in hemodialysis patients. J Ren Nutr 10(1):16-23, 2000
104. Bonomini M, Forster S, De Risio F, Rychly J, Nebe B, Manfrini V, Klinkmann H, Albertazzi A: Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis. Nephrol Dial Transplant 10(9):1654-1661, 1995
105. Perry CC, Keeling-Tucker T: Aspects of the bioinorganic chemistry of silicon in conjunction with the biometals calcium, iron and aluminium. J Inorg Biochem 69(3):181-191, 1998
106. Jugdaohsingh R: Silicon and bone health. J Nutr Health Aging 11(2):99-110, 2007
107. D'Haese PC, Shaheen FA, Huraib SO, Djukanovic L, Polenakovic MH, Spasovski G, Shikole A, Schurgers ML, Daneels RF, Lamberts LV, van Landeghem GF, deBroe ME: Increased silicon levels in dialysis patients due to high silicon content in the drinking water, inadequate water treatment procedures, and concentrate contamination: a multicentre study. Nephrol Dial Transplant 10(10):1838-1844, 1995
108. Gitelman HJ, Alderman FR, Perry SJ: Silicon accumulation in dialysis patients. Am J Kidney Dis 19(2):140-143, 1992
109. van Landeghem GF, de Broe ME, D'Haese PC: Al and Si: their speciation, distribution, and toxicity. Clin Biochem 31(5):385-397, 1998
110. Saldanha LF, Gonick HC, Rodriguez HJ, Marmelzat JA, Repique EV, Marcus CL: Silicon-related syndrome in dialysis patients. Nephron 77(1):48-56, 1997
111. Parry R, Plowman D, Delves HT, Roberts NB, Birchall JD, Bellia JP, Davenport A, Ahmad R, Fahal I, Altmann P: Silicon and aluminium interactions in haemodialysis patients. Nephrol Dial Transplant 13(7):1759-1762, 1998
112. Verma S, Cam MC, McNeill JH: Nutritional factors that can favorably influence the glucose/insulin system: vanadium. J Am Coll Nutr 17(1):11-18, 1998
113. Srivastava AK: Anti-diabetic and toxic effects of vanadium compounds. Mol Cell Biochem 206(1-2):177-182, 2000
114. Coderre L, Srivastava AK: Vanadium and the cardiovascular functions. Can J Physiol Pharmacol 82(10):833-839, 2004
115. Hosokawa S, Yoshida O: Serum vanadium levels in chronic hemodialysis patients. Nephron 64(3):388-394, 1993
116. Stefanidou M, Maravelias C, Dona A, Spiliopoulou C: Zinc: a multipurpose trace element. Arch Toxicol 80(1):1-9, 2006
117. Maret W, Sandstead HH: Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 20(1):3-18, 2006
118. Murakami M, Hirano T: Intracellular zinc homeostasis and zinc signaling. Cancer Sci 99(8):1515-1522, 2008
119. Kim YS, Kang HS, Herbert R, Beak JY, Collins JB, Grissom SF, Jetten AM: Kruppel-like zinc finger protein Glis2 is essential for the maintenance of normal renal functions. Mol Cell Biol 28(7):2358-2367, 2008
120. Zheng Y, Li XK, Wang Y, Cai L: The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators. Hemoglobin 32(1-2):135-145, 2008
121. Nations SP, Boyer PJ, Love LA, Burritt MF, Butz JA, Wolfe GI, Hynan LS, Reisch J, Trivedi JR: Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 71(9):639-643, 2008
122. Hedera P, Peltier A, Fink JK, Wilcock S, London Z, Brewer GJ: Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin II. The denture cream is a primary source of excessive zinc. Neurotoxicology 30(6):996-999, 2009
123. Cabral PC, Diniz Ada S, de Arruda IK: Vitamin A and zinc status in patients on maintenance haemodialysis. Nephrology (Carlton) 10(5):459-463, 2005
124. Mafra D, Cuppari L, Favaro DI, Cozzolino SM: Zinc levels after iron supplementation in patients with chronic kidney disease. J Ren Nutr 14(3):164-169, 2004
125. Erten Y, Kayatas M, Sezer S, Ozdemir FN, Ozyigit PF, Turan M, Haberal A, Guz G, Kaya S, Bilgin N: Zinc deficiency: prevalence and causes in hemodialysis patients and effect on cellular immune response. Transplant Proc 30(3):850-851, 1998
126. Jern NA, VanBeber AD, Gorman MA, Weber CG, Liepa GU, Cochran CC: The effects of zinc supplementation on serum zinc concentration and protein catabolic rate in hemodialysis patients. J Ren Nutr 10(3):148-153, 2000
127. Chevalier CA, Liepa G, Murphy MD, Suneson J, Vanbeber AD, Gorman MA, Cochran C: The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients. J Ren Nutr 12(3):183-189, 2002
128. Sprenger KB, Bundschu D, Lewis K, Spohn B, Schmitz J, Franz HE: Improvement of uremic neuropathy and hypogeusia by dialysate zinc supplementation: a double-blind study. Kidney Int Suppl 16:S315-S318, 1983
129. Mahajan SK, Prasad AS, Lambujon J, Abbasi AA, Briggs WA, McDonald FD: Improvement of uremic hypogeusia by zinc: a double-blind study. Am J Clin Nutr 33(7):1517-1521, 1980
130. Matson A, Wright M, Oliver A, Woodrow G, King N, Dye L, Blundell J, Brownjohn A, Turney J: Zinc supplementation at conventional doses does not improve the disturbance of taste perception in hemodialysis patients. J Ren Nutr 13(3):224-228, 2003
131. KDOQI Work Group: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl. 3):S1-S201, 2003
132. Caramelo CA, Cannata JB, Rodeles MR, Fernandez Martin JL, Mosquera JR, Monzu B, Outeirino J, Blum G, Andrea C, Lopez Farre AJ, et al.: Mechanisms of aluminum-induced microcytosis: lessons from accidental aluminum intoxication. Kidney Int 47(1):164-168, 1995
133. Ryan TP, McElwain LL, Murphy TD, Anderson SA: Elevated serum aluminum levels in hemodialysis patients associated with use of electric pumps - Wyoming, 2007. MMWR Morb Mortal Wkly Rep 57(25):689-691, 2008
134. Burwen DR, Olsen SM, Bland LA, Arduino MJ, Reid MH, Jarvis WR: Epidemic aluminum intoxication in hemodialysis patients traced to use of an aluminum pump. Kidney Int 48(2):469-474, 1995
135. Reinke CM, Breitkreutz J, Leuenberger H: Aluminium in over-the-counter drugs: risks outweigh benefits? Drug Saf 26(14):1011-1025, 2003
136. Hemstreet BA: Use of sucralfate in renal failure. Ann Pharmacother 35(3):360-364, 2001
137. Gura KM: Aluminum contamination in products used in parenteral nutrition: has anything changed? Nutrition 26(6):585-594, 2010
138. Wills MR, Savory J: Aluminum and chronic renal failure: sources, absorption, transport, and toxicity. Crit Rev Clin Lab Sci 27(1):59-107, 1989
139. Yaman M, Gunes M, Bakirdere S: Contamination of aluminium from cooking utensils and yogurt containers. Bull Environ Contam Toxicol 70(3):437-442, 2003
140. Rajwanshi P, Singh V, Gupta MK, Kumari V, Shrivastav R, Ramanamurthy M, Dass S: Studies on aluminium leaching from cookware in tea and coffee and estimation of aluminium content in toothpaste, baking powder and paan masala. Sci Total Environ 193(3):243-249, 1997
141. Jaffe JA, Liftman C, Glickman JD: Frequency of elevated serum aluminum levels in adult dialysis patients. Am J Kidney Dis 46(2):316-319, 2005
142. Navarro-Gonzalez JF, Mora-Fernandez C, Garcia-Perez J: Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial 22(1):37-44, 2009
143. Navarro JF, Mora C, Jimenez A, Torres A, Macia M, Garcia J: Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis 34(1):43-48, 1999
144. Jung GJ, Gil HW, Yang JO, Lee EY, Hong SY: Severe hypermagnesemia causing quadriparesis in a CAPD patient. Perit Dial Int 28(2):206, 2008
145. O'Donovan R, Baldwin D, Hammer M, Moniz C, Parsons V: Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia. Lancet 1(8486):880-882, 1986
146. Wei M, Esbaei K, Bargman J, Oreopoulos DG: Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review. Perit Dial Int 26(3):366-373, 2006
147. Elsharkawy MM, Youssef AM, Zayoon MY: Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Hemodial Int 10(Suppl. 2):S16-S23, 2006
148. Tzanakis IP, Papadaki AN, Wei M, Kagia S, Spadidakis VV, Kallivretakis NE, Oreopoulos DG: Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial. Int Urol Nephrol 40(1):193-201, 2008
149. Tzanakis IP, Oreopoulos DG: Beneficial effects of magnesium in chronic renal failure: a foe no longer. Int Urol Nephrol 41(2):363-371, 2009
150. de Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, Scholz C, Ponce P, Passlick-Deetjen J: Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant, 25(11):3707-3717, 2010
151. The higher intracellular magnesium, the better long-term survival on hemodialysis. 39th ASN Congress; 2006; San Diego.
152. Kanbay M, Goldsmith D, Uyar ME, Turgut F, Covic A: Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif 29(3):280-292, 2010
153. Navarro Silvera SA, Rohan TE: Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control 18(1):7-27, 2007
154. Beyersmann D, Hartwig A: Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch Toxicol 82(8):493-512, 2008
155. Wright RO, Baccarelli A: Metals and neurotoxicology. J Nutr 137(12):2809-2813, 2007
156. Rana SV: Metals and apoptosis: recent developments. J Trace Elem Med Biol 22(4):262-284, 2008
157. Nicolay A, Bertocchio P, Bargas E, Reynier JP: Long-term follow up of ionic plasma fluoride level in patients receiving hemodialysis treatment. Clin Chim Acta 263(1):97-104, 1997
158. Zachara BA, Gromadzinska J, Zbrog Z, Swiech R, Wasowicz W, Twardowska E, Jablonska E, Sobala W: Selenium supplementation to chronic kidney disease patients on hemodialysis does not induce the synthesis of plasma glutathione peroxidase. Acta Biochim Pol 56(1):183-187, 2009